🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. CMX001

    Jazz Pharmaceuticals Ireland Limited

    Ebola Virus

    phase 2 small molecule terminated

    1 trial

  2. CORT113176, CORT113176, Placebo to Dazucorilant softgel capsule

    CORCEPT THERAPEUTICS INC

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule active

    1 trial

  3. COVAXIN(BBV152)

    Biotech Pharmaceutical Co.,

    Corona Virus Infection

    phase 2 mab completed

    1 trial

  4. CPGJ602

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    2 trials

  5. CPK850

    Novartis Pharmaceuticals

    Retinitis pigmentosa caused by biallelic mutations in the RLBP1 gene

    phase 2 small molecule active

    1 trial

  6. CPP-109 vigabatrin

    CATALYST PHARMACEUTICALS, INC.

    Methamphetamine Dependence

    phase 2 small molecule terminated

    1 trial

  7. CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection

    Jazz Pharmaceuticals Ireland Limited

    Colorectal Neoplasms

    phase 2 small molecule completed

    1 trial

  8. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia (AML) in Remission

    phase 2 small molecule active

    1 trial

  9. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Lymphoid Leukemia

    phase 2 small molecule completed

    1 trial

  10. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Leukemia, Myeloid, Acute

    phase 2 small molecule completed

    1 trial

  11. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia (AML)

    phase 2 small molecule completed

    2 trials

  12. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Myeloid Neoplasm

    phase 2 small molecule active

    1 trial

  13. CPX-351

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 small molecule completed

    7 trials

  14. CRB-601 monoclonal antibody

    Corbus Pharmaceuticals Holdings

    Solid Tumor

    phase 2 small molecule active

    1 trial

  15. CRB-701

    Corbus Pharmaceuticals Holdings

    Solid Tumor, Adult

    phase 2 small molecule active

    1 trial

  16. CRD-4730, CRD-4730 matching placebo

    Lacuna Pharma Pty Ltd

    Catecholaminergic Polymorphic Ventricular Tachycardia

    phase 2 small molecule active

    1 trial

  17. CRN09682

    Crinetics Pharmaceuticals Europe GmbH

    SST2-positive Neuroendocrine Neoplasms

    phase 2 small molecule active

    1 trial

  18. CRV431 75mg

    Hepion Pharmaceuticals

    NASH - Nonalcoholic Steatohepatitis

    phase 2 small molecule completed

    1 trial

  19. CS1001

    Cstone Pharmaceuticals Ireland Limited

    Advanced Refractory Solid Tumors

    phase 2 small molecule completed

    1 trial

  20. CSG452 (Tofogliflozin) placebo, pemafibrate, K-877 ER (Pemafibrate) placebo, TOFOGLIFLOZIN

    The George Institute

    Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis

    phase 2 small molecule active

    1 trial

  21. CSJ117

    Novartis Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    2 trials

  22. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non-small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  23. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced NSCLC

    phase 2 small molecule terminated

    1 trial

  24. CT053PTSA

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Renal Cell Cancer Metastatic

    phase 2 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources